By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Leukemia and Lymphoma Society has awarded a $6.3 million grant for research at the University of Cambridge that will use genome-wide analysis to study drug responses used for blood cancer treatment, LLS said Monday.

The grant, which provides $1.25 million per year for five years, was funded under the LLS Marshall A. Lichtman Specialized Center of Research (SCOR) grant program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."